Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
OFIX 
Orthofix Medical Inc (OFIX)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/03/2025: OFIX (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
5 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $22.8
1 Year Target Price $22.8
| 2 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -61.57% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 12/03/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 630.43M USD | Price to earnings Ratio - | 1Y Target Price 22.8 |
Price to earnings Ratio - | 1Y Target Price 22.8 | ||
Volume (30-day avg) 5 | Beta 0.83 | 52 Weeks Range 10.24 - 20.48 | Updated Date 12/3/2025 |
52 Weeks Range 10.24 - 20.48 | Updated Date 12/3/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -3.03 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-11-06 | When - | Estimate -0.3315 | Actual 0.1976 |
Profitability
Profit Margin -14.56% | Operating Margin (TTM) -8.35% |
Management Effectiveness
Return on Assets (TTM) -5.69% | Return on Equity (TTM) -24.6% |
Valuation
Trailing PE - | Forward PE 37.74 | Enterprise Value 769672591 | Price to Sales(TTM) 0.77 |
Enterprise Value 769672591 | Price to Sales(TTM) 0.77 | ||
Enterprise Value to Revenue 0.94 | Enterprise Value to EBITDA 146.21 | Shares Outstanding 39599659 | Shares Floating 39113771 |
Shares Outstanding 39599659 | Shares Floating 39113771 | ||
Percent Insiders 2.4 | Percent Institutions 91.46 |
Upturn AI SWOT
Orthofix Medical Inc
Company Overview
History and Background
Orthofix Medical Inc. was founded in 1980. Initially focused on external fixation devices, it has grown through acquisitions and product development to offer a broader portfolio of orthopedic and spine solutions. Key milestones include expanding into bone growth stimulation and acquiring companies specializing in spine implants and biologics.
Core Business Areas
- Spine: Includes spinal implants, biologics, and motion preservation technologies used in surgical procedures to treat spinal disorders.
- Orthopedics: Focuses on fracture management, limb reconstruction, and bone growth stimulation devices for orthopedic trauma and reconstruction.
- Biologics: Offers a range of biologics products used to promote bone and tissue healing.
Leadership and Structure
The leadership team includes the CEO, CFO, and various VPs overseeing different business units. The organizational structure is typically hierarchical, with distinct divisions for each core business area, supported by functions like R&D, sales, marketing, and operations.
Top Products and Market Share
Key Offerings
- FORZAu2122 Interbody System: Spinal implant designed to restore disc height and stabilize the spine. Market share data is proprietary, but it competes with Medtronic and Stryker in the interbody fusion market.
- Physio-Stimu2122 Bone Growth Stimulators: Non-invasive devices used to stimulate bone healing in fractures and fusions. Exact market share data is not public, but it is a major player in the bone growth stimulation market, competing with Bioventus and DJO Global.
- JuniORu2122 Adjustable Fixation System: External fixation system used for pediatric limb reconstruction. Competitive with DePuy Synthes and Smith & Nephew
Market Dynamics
Industry Overview
The orthopedic and spine market is driven by an aging population, increasing rates of obesity, and advancements in surgical techniques and technologies. It is highly competitive and regulated.
Positioning
Orthofix Medical Inc. is a mid-sized player in the orthopedic and spine market, with a focus on innovation and customer service. Its competitive advantages include a diversified product portfolio and a strong sales force.
Total Addressable Market (TAM)
The global orthopedic devices market is projected to reach hundreds of billions of dollars. Orthofix Medical Inc. is positioned to capture a portion of this TAM through its product portfolio and market strategies.
Upturn SWOT Analysis
Strengths
- Diversified product portfolio
- Strong sales force
- Innovative technology
- Established brand reputation
Weaknesses
- Smaller market share compared to larger competitors
- Dependence on reimbursement policies
- Potential product liability risks
- High debt levels
Opportunities
- Expanding into emerging markets
- Developing new products and technologies
- Acquiring complementary businesses
- Capitalizing on demographic trends
Threats
- Increased competition
- Pricing pressures
- Changes in healthcare regulations
- Economic downturns
Competitors and Market Share
Key Competitors
- MDT
- STRY
- BSX
- ZBH
Competitive Landscape
Orthofix Medical Inc. faces intense competition from larger, more established companies with greater resources. To compete effectively, it must continue to innovate, differentiate its products, and provide exceptional customer service.
Major Acquisitions
SeaSpine Holdings Corporation
- Year: 2023
- Acquisition Price (USD millions): 306.7
- Strategic Rationale: Merger to broaden spine product portfolio, expand distribution, and achieve cost synergies.
Growth Trajectory and Initiatives
Historical Growth: Historical growth can be charted by pulling financial performance and revenue from historical data from companies financial reports and Yahoo Finance
Future Projections: Future projections can be found through analyst reports. Access this data through companies financial reports and Yahoo Finance.
Recent Initiatives: Recent initiatives include product launches, acquisitions, and partnerships.
Summary
Orthofix Medical Inc. is a mid-sized player in the orthopedic and spine market with a diversified product portfolio. The company benefits from innovation and a strong sales force, but faces competition from larger companies and pressures on pricing. Recent acquisitions and strategic initiatives point towards growth, but regulatory changes and economic conditions pose challenges. Orthofix needs to continue to innovate and adapt in order to thrive.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings, Analyst reports, Industry publications, Press releases
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market share data is based on estimates and may vary. Actual financial performance may differ from projections.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Orthofix Medical Inc
Exchange NASDAQ | Headquaters Lewisville, TX, United States | ||
IPO Launch date 1992-04-24 | President, CEO & Director Mr. Massimo Calafiore | ||
Sector Healthcare | Industry Medical Devices | Full time employees 1616 | Website https://orthofix.com |
Full time employees 1616 | Website https://orthofix.com | ||
Orthofix Medical Inc. operates as a medical technology company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulation devices that enhance bone fusion, including adjunctive and noninvasive treatment of the cervical and lumbar spine, as well as a therapeutic treatment for non-spinal, appendicular fractures, and fresh fractures that have not healed; designs, develops, and markets a portfolio of spine fixation and motion preservation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and provides 7D flash navigation system for spine and cranial procedures. Its Global Orthopedics segment offers products and solutions that allow physicians to treat various orthopedic conditions related to limb reconstruction and deformity correction unrelated to the spine. This segment designs, develops, and markets external and internal fixation orthopedic products that are coupled with enabling digital technologies to serve the complete patient treatment pathway. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, and healthcare providers. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.